Teva Neuroscience, Inc. clinical trials
Acquired by Teva Pharmaceutical Industries, Ltd.
The registry lists 10 studies whose lead sponsor is Teva Neuroscience, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 6, 2017.
Registry sponsor names on this page
- Teva Neuroscience, Inc.10 studies
Something wrong with this grouping? Tell us on the Teva Pharmaceutical Industries, Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Teva Pharmaceutical Industries, Ltd. studies →
- A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®CompletedNCT00239993Phase 4
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's DiseaseCompletedNCT01049984Phase 4
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- Evaluation of Two Glatiramer Acetate (GA) Formulations in Relapsing-Remitting Multiple Sclerosis (RRMS) PatientsCompletedNCT01167426Phase 3
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- A Multi-Dose Study to Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-DeficiencyCompletedNCT00455260Phase 1
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- Therapy Optimization in Multiple Sclerosis (MS)CompletedNCT00819000
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With LevodopaCompletedNCT00203060Phase 3
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's DiseaseCompletedNCT00399477Phase 4
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® TherapyCompletedNCT00238654
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® AloneCompletedNCT00240006Phase 4
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group
- A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.CompletedNCT00220922Phase 4
Sponsor listed in the registry: Teva Neuroscience, Inc. · Teva Neuroscience, Inc. — acquired company within the Teva Pharmaceutical Industries, Ltd. group